Voice your opinion on congressional bill HR3276-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act

This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.

HR4378-116, S1785-116, HR3253-116,

House committee actions Actions

Committee
Jun. 14 2019	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral
Jun. 13 2019	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

IntroReferral
Jun. 13 2019	Introduced in House Introduced in House

House bill HR3276-116

Fair AMP Act

Promote the cause!

Or use this QR code